Phathom Pharmaceuticals (PHAT) Net Margin Growth (1y) (2024 - 2026)

Phathom Pharmaceuticals (PHAT) Net Margin Growth (1y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Phathom Pharmaceuticals 951.79 Mn 768.02 Mn 46.31 Mn 24,835.00

Historic Data

Download Data
DateValue
Mar 31, 2026 24,835.00
Dec 31, 2025 21,443.00
Sep 30, 2025 61,431.00
Jun 30, 2025 103,733.00
Mar 31, 2025 400,038.00
Dec 31, 2024 1.45 Mn